Prevalence of Gestational Diabetes Mellitus in Eastern and Southeastern Asia: A Systematic Review and Meta-Analysis.
Prevalence of Gestational Diabetes Mellitus in Eastern and Southeastern Asia: A Systematic Review and Meta-Analysis.
复制标题
DOI：
10.1155/2018/6536974
复制
发表时间：
2018
影响因子：
4.3
通讯作者：
Lee AH
中科院分区：
文献类型：
--
作者：
Nguyen CL;Pham NM;Binns CW;Duong DV;Lee AH
回顾东亚和东南亚妊娠期糖尿病（GDM）的患病率。 我们系统地检索了2000年1月至2016年12月期间关于GDM患病率的观察性研究。纳入标准为英文原创论文，全文发表在同行评审期刊上。采用澳大利亚国家健康和医学研究理事会的指导方针评价纳入研究的质量。固定效应和随机效应模型用于估计GDM的总体患病率和相应的95%置信区间（CI）。 共筛选了4415篇论文，最终纳入48项研究，其中63项GDM患病率观察结果。GDM的合并患病率为10.1%（95%CI：6.5%-15.7%），尽管各国之间存在很大差异。低收入或中上收入国家的GDM患病率比高收入国家高约64%。此外，一步筛选方法是两倍更有可能被用于诊断GDM相比，两步筛选程序。 GDM在东亚和东南亚的流行率很高，并且在国家之间和国家内部各不相同。GDM的筛查策略和诊断标准需要国际统一。
To review the prevalence of gestational diabetes mellitus (GDM) in Eastern and Southeastern Asia. We systematically searched for observational studies on GDM prevalence from January 2000 to December 2016. Inclusion criteria were original English papers, with full texts published in peer-reviewed journals. The quality of included studies was evaluated using the guidelines of the National Health and Medical Research Council, Australia. Fixed effects and random effects models were used to estimate the summary prevalence of GDM and the corresponding 95% confidence intervals (CI). A total of 4415 papers were screened, and 48 studies with 63 GDM prevalence observations were included in the final review. The pooled prevalence of GDM was 10.1% (95% CI: 6.5%–15.7%), despite substantial variations across nations. The prevalence of GDM in lower- or upper-middle income countries was about 64% higher than in their high-income counterparts. Moreover, the one-step screening method was twice more likely to be used in diagnosing GDM when compared to the two-step screening procedure. The prevalence of GDM in Eastern and Southeastern Asia was high and varied among and within countries. There is a need for international uniformity in screening strategies and diagnostic criteria for GDM.
登录
查看更多内容
DOI：
10.1016/0197-2456(86)90046-2
发表时间：
1986-09-01
期刊：
CONTROLLED CLINICAL TRIALS
影响因子：
--
作者：
DERSIMONIAN, R;LAIRD, N
通讯作者：
LAIRD, N
影响因子：
105.7
作者：
GARDNER, MJ;ALTMAN, DG
通讯作者：
ALTMAN, DG
影响因子：
11.1
作者：
Barker, D. J. P.
通讯作者：
Barker, D. J. P.
影响因子：
5.1
作者：
Guariguata, L.;Linnenkamp, U.;Cho, N. H.
通讯作者：
Cho, N. H.
DOI：
10.1016/0002-9378(82)90349-0
发表时间：
1982-01-01
影响因子：
9.8
作者：
CARPENTER, MW;COUSTAN, DR
通讯作者：
COUSTAN, DR